BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17049941)

  • 1. Rhabdomyolysis due to severe hypokaliemia in a Crohn's disease patient after budesonide treatment.
    Mangone M; Spagnolo A; Capurso G; Marignani M; Panzuto F; Angeletti S; Ruggeri M; Menè P; Delle Fave G
    Dig Liver Dis; 2007 Aug; 39(8):776-9. PubMed ID: 17049941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide for Crohn's disease.
    Seow CH; Benchimol EI; Steinhart AH; Griffiths AM; Otley AR
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):971-9. PubMed ID: 19611401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophagitis in an adolescent patient with Crohn's disease after changing treatment from prednisolone to budesonide.
    Weigand K; Wagner-Thiessen E; Stolte M
    Z Gastroenterol; 2004 Oct; 42(10):1179-81. PubMed ID: 15508059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission.
    de Jong DJ; Bac DJ; Tan G; de Boer SY; Grabowsky IL; Jansen JB; Greinwald R; Naber TH
    Neth J Med; 2007 Oct; 65(9):339-45. PubMed ID: 17954953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Crohn's disease with budesonide: this rose still has thorns!
    Valentine JF
    Am J Gastroenterol; 2002 Apr; 97(4):785-6. PubMed ID: 12003409
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug prevention of Crohn disease recurrence in the neo-terminal ileum after ileocolic resection].
    Vermeire S; Rutgeerts P
    Zentralbl Chir; 1998; 123(4):352-6. PubMed ID: 9622893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypokaliemia and metabolic alkalosis in a Crohn's disease patient after budesonide treatment: evidence for intestinal secretion of potassium.
    Elriz K; Savoye G; Tamion F; Déchelotte P; Lerebours E
    Dig Liver Dis; 2008 Feb; 40(2):149-50. PubMed ID: 18082475
    [No Abstract]   [Full Text] [Related]  

  • 8. Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study.
    Tursi A; Giorgetti GM; Brandimarte G; Elisei W; Aiello F
    Med Sci Monit; 2006 Jun; 12(6):PI29-32. PubMed ID: 16733496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [L-carnitine chloride and potassium chloride in the treatment of a case of non-traumatic rhabdomyolysis without myoglobinuria caused by the ingestion of liquorice].
    Ruggeri CS; Olivari G; Benvenuti ME; De Iacobis M; Peruzza M; Chinello M; Mazzolini GF; Rubini G
    Minerva Med; 1985 Apr; 76(14-15):725-8. PubMed ID: 3991034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypokalemia after budesonide treatment for Crohn's disease.
    Rosenbach Y; Zahavi I; Rachmal A; Dinari G
    J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):352-5. PubMed ID: 9138184
    [No Abstract]   [Full Text] [Related]  

  • 11. [Crohn's disease and ascites].
    Aparicio Tormo JR; Laveda R; Gómez Andrés A
    Gastroenterol Hepatol; 2000 Oct; 23(8):384-8. PubMed ID: 11227652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
    Abreu MT
    Nat Clin Pract Gastroenterol Hepatol; 2005 May; 2(5):210-1. PubMed ID: 16265201
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral budesonide for maintenance of remission of Crohn's disease: a pooled safety analysis.
    Lichtenstein GR; Bengtsson B; Hapten-White L; Rutgeerts P
    Aliment Pharmacol Ther; 2009 Mar; 29(6):643-53. PubMed ID: 19035972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-artery stroke in a young patient with Crohn's disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia.
    Younes-Mhenni S; Derex L; Berruyer M; Nighoghossian N; Philippeau F; Salzmann M; Trouillas P
    J Neurol Sci; 2004 Jun; 221(1-2):113-5. PubMed ID: 15178225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide in Crohn's disease: findings of a compassionate-use program.
    Lyckegaard E; Håkansson K; Bengtsson B
    Hepatogastroenterology; 2007; 54(79):2024-7. PubMed ID: 18251152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral budesonide in the management of Crohn's disease.
    Hofer KN
    Ann Pharmacother; 2003 Oct; 37(10):1457-64. PubMed ID: 14519035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute rhabdomyolysis: a case report and literature review].
    Mrsić V; Nesek Adam V; Grizelj Stojcić E; Rasić Z; Smiljanić A; Turcić I
    Acta Med Croatica; 2008 Jul; 62(3):317-22. PubMed ID: 18843854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2 cases of severe hypokalemia with acute rhabdomyolysis].
    Dal Fabbro S; Salvadego L; Bridda A
    Recenti Prog Med; 1990 Sep; 81(9):576-8. PubMed ID: 2263752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry eye syndrome and cataract as ocular manifestations of Crohn's disease.
    Mrugacz M; Sredzińska-Kita D; Cyrta-Jarocka E; Bakunowicz-Lazarczyk A
    Klin Oczna; 2005; 107(7-9):509-10. PubMed ID: 16417009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide modified-release capsules.
    Baker DE
    Rev Gastroenterol Disord; 2001; 1(3):147-55. PubMed ID: 12120182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.